Professor Marja-Riitta Taskinen
Disclosure details
Marja-Riitta Taskinen has been receiving consulting fees or paid for advisory boards from Amgen, Novo Nordisk, Eli Lilly, Chiesi Pharm, Mylan and Akcea.Emerita Professor of Medicine, Biomedicum Helsinki, University of Helsinki, Finland
